FDA
-
-
-
-
-
-
-
Applied Molecular Transport (AMTI) Reports Top-line Phase 2 Results from LOMBARD Monotherapy Trial of AMT-101
-
-
-
-
-
-
-
Applied Molecular Transport Reports Third Quarter 2022 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Applied Molecular Transport Announces Top-line Phase 2 Results from MARKET Combination Trial of Oral AMT-101 in Patients with Moderate-to-Severe Ulcerative Colitis
-
-
-
-
-
-
249,556 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All